IPEDs - FOI Response Register

1. How much did the health board spend on the treatment of Image and Performance Enhancing Drugs (IPEDs), such as steroids or Selective Androgen Receptor Modulators (SARMs), in the last three financial years?

In accordance with FOISA s 17(1), NHS Shetland confirms that it does not hold the information requested.

2. What specialised services, if any, does your board offer in relation to IPEDs?

NHS Shetland do not provide this service

3. What training on IPEDs do you offer staff? How many staff have undergone this training?

NHS Shetland do not offer training on IPEDs

4. How many people were treated for harms resulting from IPED use? Please provide this information for the last three years you have data.

NHS Shetland uses the ICD 10 coding system. Figures provided are for the number of inpatients where ICD 10 codes F55.3 (Abuse of steroids or hormones) or T38.7 (Poisoning by, adverse effect of and under dosing of androgens and anabolic congeners) were listed as Main Condition or Other Condition.

Where we have given <5 answers this is because NHS Shetland considers that providing more specific information carries a high risk of identifying individuals. As such and in accordance with FOISA s 16(1), NHS Shetland confirms that it holds the information requested but that it is exempt from disclosure under FOISA s 38(1)(b) as read with s 38 (2A) as the information constitutes personal data and disclosure would breach the confidentiality of the data subjects.

5. Please provide a demographic breakdown, if possible, of any patients treated for harms resulting from IPED use.

In accordance with FOISA s 16(1), NHS Shetland confirms that it holds the information requested but that it is exempt from disclosure under FOISA s 38(1)(b) as read with s 38 (2A) as the information constitutes personal data and disclosure would breach the confidentiality of the data subjects.

6. Please provide information as to what screening methods you use (formal and informal) for IPED use when discussing kidney, hepatic, and cardiovascular disorders with patients.

In accordance with FOISA s 17(1), NHS Shetland confirms that it does not hold the information requested.

7. Please provide information about what public health awareness initiatives you have ran within the last five years to raise awareness of the potential harms of IPED use in your health board area.

There have been no initiatives on this topic.

8. Please provide information about any working groups, internal meetings, or co-design initiatives looking at the impact of IPEDs. If you have any such groups, please provide their terms of reference, and minutes of their last six meetings.

N/A